Data showed a 93.4% overall diagnostic agreement, indicating that HeartBeam’s synthesized 12-lead ECG can support diagnosis of arrhythmias in a manner consistent with standard 12-lead ECGs.

Data from the pilot study presented at the AHA Scientific Sessions, which also supported the FDA submission, found similar performance of HeartBeam’s synthesized 12-lead ECG waveforms compared ...

The study's lead author, Richard Becker, MD, ... It was tested in a prospective, single-blind study of 200 heart patients against the standard traditional 12-lead EKG procedure.